| Patents for C07D 241 - Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings (18,673) |
|---|
| 08/14/2003 | WO2003065789A2 N-biphenylmethyl aminocycloalkanecarboxamide derivatives |
| 08/14/2003 | WO2003024955A3 Small molecule inhibitors of caspases |
| 08/14/2003 | WO2003019145A3 Non-fluorescent quencher compounds and biomolecular assays |
| 08/14/2003 | US20030153753 Process for the preparation of a piperazine derivative |
| 08/14/2003 | US20030153596 Novel thiourea derivatives and the pharmaceutical compositions containing the same |
| 08/14/2003 | US20030153530 Solubility enhancing component other than a cyclodextrin, particularly a polyanionic component, an oxy-chloro component to aid in preserving the composition, liquid carrier |
| 08/14/2003 | US20030153510 Novel compounds inhibiting factor xa activity |
| 08/14/2003 | CA2474214A1 Novel aryl- and heteroarylpiperazines |
| 08/14/2003 | CA2473778A1 N-biphenylmethyl aminocycloalkanecarboxamide derivatives |
| 08/13/2003 | EP1334083A2 1,4-disubstituted benzenes as insecticides |
| 08/13/2003 | EP1305445A4 Dark quenchers for donor-acceptor energy transfer |
| 08/13/2003 | EP1242427B1 Novel piperidine and piperazine derivatives as p2x7 receptor antagonists |
| 08/13/2003 | CN1436193A Antitumoral ecteinascidin derivs |
| 08/13/2003 | CN1436168A Beta-amino acid nitrile derivs. |
| 08/12/2003 | US6605124 Naphthol hair dyes for keratinous fibers |
| 08/07/2003 | WO2003063797A2 Cycloalkyl inhibitors of potassium channel function |
| 08/07/2003 | WO2003030886A3 Allylamides useful in the treatment of alzheimer's disease |
| 08/07/2003 | US20030149055 Bicyclic compounds as inhibitors of chemokine binding to US28 |
| 08/07/2003 | US20030149053 Reacting acid salt of aminoacetamidine with a source-of cyanide and reacting with 2,3,5- trichlorobenzaldehyde to produce 2-((Cyano-(2,3,5-trichlorophenyl)-methyl)-amino)-acetamidine or a salt thereof |
| 08/07/2003 | US20030149052 Side effect reduction |
| 08/07/2003 | US20030149038 Alpha-helix mimicry by a class of organic molecules |
| 08/07/2003 | US20030148188 Active materials in the positive electrodes of batteries. Novel methods for preparing the tetraketopiperazine unit-containing compounds include: (i) reacting an oxalyl halide and an oxamide, and adding water or an aqueous alkali |
| 08/07/2003 | CA2474451A1 Cycloalkyl inhibitors of potassium channel function |
| 08/06/2003 | EP1332138A1 Radiopharmaceuticals for diagnosing alzheimer's disease |
| 08/06/2003 | CN1434827A 新的哌啶和哌嗪衍生物 The new piperidine and piperazine derivatives |
| 08/06/2003 | CN1434807A Pyrazine based inhibitors of glycogen synthase kinase 3 |
| 08/06/2003 | CN1117092C Azadicyclic compound, its medicinal composition and medicinal use |
| 08/06/2003 | CN1117085C Sparfloxacin salt and synthesis method and use thereof |
| 08/06/2003 | CN1117071C Pesticides |
| 08/05/2003 | US6603003 Method for the preparation of piperazine and its derivatives |
| 08/05/2003 | US6602875 Sorbitol dehydrogenase inhibitors |
| 08/05/2003 | CA2275827C Method for treating glaucoma |
| 07/31/2003 | WO2003061643A1 Pharmaceutical composition that is used to control blood glucose in patients with type 2 diabetes |
| 07/31/2003 | WO2003027061A3 Muscarinic agonists |
| 07/31/2003 | US20030144526 Calcium receptor-active compounds |
| 07/31/2003 | US20030144328 Compounds which inhibit leukocyte adhesion mediated by VLA-4 |
| 07/31/2003 | US20030144297 Substituted aryl 1,4-pyrazine derivatives |
| 07/31/2003 | US20030144284 Heterocyclic imines such as 2-anilino-6-quinoxalinol, used to suppress cell proliferation, differentiation, chemotaxis and/or activation; prophylaxis of restinosis; anticarcinogenic agents |
| 07/31/2003 | US20030144277 Piperizinones as modulators of chemokine receptor activity |
| 07/31/2003 | US20030144276 Heterocycle-containing carboxylic acid derivative and drug containing the same |
| 07/31/2003 | US20030144272 Heterocyclic amines such as 2-(2-(N-Methylsulfamoyl)-4-methoxy -phenyl)-N-methyl-N-((1S)-1-phenyl-2-((1-pyrrolidinyl)ethyl)) acetamide, administered as analgesics |
| 07/30/2003 | EP1330452A2 Pyrazine derivatives as modulators of tyrosine kinases |
| 07/30/2003 | CN1433406A BenzoÒÇöaÒÇòphenazin-11-carboxamide derivatives and their use as joint inhibitors of topomerase I and Ôàí" |
| 07/30/2003 | CN1116285C Bis (acridinecarboxamide) and Bis (phenazinecarboxamide) as antitumour agents |
| 07/30/2003 | CN1116277C Process for preparing carbocylic or heterocyclic nitriles by vapor phase ammoxidation |
| 07/30/2003 | CN1116271C Method of producing 2-substituted-3,4-fused heterocycle benzoic acid |
| 07/29/2003 | US6599905 Pyrazine compounds |
| 07/29/2003 | US6599903 Derivatives of 2-(iminomethyl)amino-phenyl, their preparation, their use as medicaments and the pharmaceutical compositions containing them |
| 07/29/2003 | CA2188690C Selective thrombin inhibitors |
| 07/24/2003 | WO2003059893A1 N-pyrazinyl-phenylsulphonamides and their use in the treatment of chemokine mediated diseases |
| 07/24/2003 | WO2003059335A1 Phenyl sulfoxides and phenyl sulfones |
| 07/24/2003 | WO2003059307A1 Cosmetic compositions comprising a cyclodipeptide compound |
| 07/24/2003 | WO2003059306A1 Cosmetic compositions comprising a cyclodipeptide compound |
| 07/24/2003 | WO2003059265A2 Compositions and methods for treating heart failure |
| 07/24/2003 | WO2003059064A1 Insecticides containing hydrazone derivatives as the active ingredient and novel hydrazone derivatives |
| 07/24/2003 | US20030139500 Compositions stabilized by dioxopiperazinyl derivatives |
| 07/24/2003 | US20030139462 Antiinflammatory agents; autoimmune disease; antiarthritic agents |
| 07/24/2003 | US20030139425 Piperazine derivatives and their use as anti-inflammatory agents |
| 07/24/2003 | US20030139409 Benzo[A] [phenazin-11-carboxamide derivatives and their use as joint inhibitors of topomerase I and II |
| 07/24/2003 | US20030139405 6-Membered heterocyclic compounds useful for selective inhibition of the coagulation cascade |
| 07/24/2003 | US20030139402 Antiinflammatory agents; Alzheimer's disease; cardiovascular disorders |
| 07/24/2003 | US20030139400 Controlling cell differentiation; antiinflammatory agents |
| 07/24/2003 | US20030139399 Quinoline and quinoxaline compounds which inhibit platelet-derived growth factor and/or p56lck tyrosine kinases |
| 07/24/2003 | US20030139379 Autoimmune disease, osteoporosis, rheumatic diseases, skin disorders |
| 07/24/2003 | US20030138662 A dibenzoquinoxaline compounds electron transporting materials; flat-panel display, electroluminescence |
| 07/24/2003 | CA2473374A1 Phenyl sulfoxides and phenyl sulfones |
| 07/24/2003 | CA2472204A1 N-pyrazinyl-phenylsulphonamides and their use in the treatment of chemokine mediated diseases |
| 07/24/2003 | CA2471607A1 Cosmetic compositions comprising a cyclodipeptide compound |
| 07/23/2003 | EP0929528B1 Aralkyl and aralkylidene heterocyclic lactams and imides |
| 07/23/2003 | CN1431202A Red fluorescence dyestuff and its synthesizing method and usage |
| 07/22/2003 | US6596878 Protein kinase inhibitor compositio; used to treat cell proliferative disorders such as cancers charcterized by over-activity or inappropriate activity HER2 or EGFR. |
| 07/22/2003 | US6596872 Process for preparing alkenyl-substituted heterocycles |
| 07/22/2003 | US6596863 Matrix metalloproteinase inhibitor is useful as an anticancer agent, angiogenesis inhibitor, a tumor cell infiltration inhibitor or a tumor metastasis inhibitor; inflammatory diseases, osteoarthritis, rheumatoid arthritis |
| 07/22/2003 | US6596721 (6S)- or 10 (6R,S)- tetrahydrofolic acid is crystallized in a polar medium with pH of 3.5 or greater and have a purity 98% |
| 07/22/2003 | US6596461 Piperazinone derivatives |
| 07/17/2003 | WO2003058667A1 Organic light-emitting devices |
| 07/17/2003 | WO2002099124A3 Characterising polypeptides |
| 07/17/2003 | US20030135063 Especially Type II diabetes; stimulating the kinase activity of the insulin receptor; activating the insulin receptor |
| 07/17/2003 | US20030134859 Substituted 2-chloro-5-nitrobenzamides; treating retrograde osteoporosis and diabetes mellitus |
| 07/17/2003 | US20030134840 Novel compounds |
| 07/17/2003 | US20030134022 Production of 2-ethyl-3-methyl-1,4 diazine |
| 07/16/2003 | EP1326867A2 Bridged piperazine derivatives |
| 07/16/2003 | EP1326865A2 Aza- and polyaza-naphthalenyl carboxamides useful as hiv integrase inhibitors |
| 07/16/2003 | EP1326857A2 Diazacycloalkanedione derivatives which are useful as lfa-1 antagonists |
| 07/16/2003 | EP1326835A1 Benzamide compounds as apo b secretion inhibitors |
| 07/16/2003 | CN1430610A Substituted 1-aminoalkyl-lactams compound and their use as muscarinic receptor antagonists |
| 07/16/2003 | CN1430609A Substituted 1-aminoalkyl-lactams compound and their use as muscarinic receptor antagonists |
| 07/16/2003 | CN1430608A Substituted iminoazines |
| 07/16/2003 | CN1430607A Benzophenones as inhibitors of IL-1 beta and TNF-alpha |
| 07/16/2003 | CN1430605A Process for synthesis of amine ethers from secondary amino oxides |
| 07/16/2003 | CN1429820A Method of preparing 2-cyanopyrazine by ammonia oxidation method and its special catalyst |
| 07/16/2003 | CN1429819A Method of preparing anti-depression medicine Midanping |
| 07/16/2003 | CN1429818A 1-methyl-3-substituted piperazine like compound and its preparation method |
| 07/16/2003 | CN1114594C D4 receptor selectivity piperazine derivatives |
| 07/15/2003 | US6593474 Adrenergic blocking agents |
| 07/15/2003 | US6593347 Nitrosated and nitrosylated nonsteroidal antiinflammatory compounds, compositions and methods of use |
| 07/15/2003 | US6593330 Compounds and their use |
| 07/15/2003 | US6593013 Electroluminescence device, cyclic azine compound and production process of cyclic azine dye |
| 07/10/2003 | WO2003055853A1 Electron-accepting compounds capable of forming self-assembled monolayers |
| 07/10/2003 | WO2003055851A1 Hydroxamic acid derivative and mmp inhibitor containing the same as active ingredient |